Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Measuring circulating tumor cells may help better predict prostate cancer survival

New research by USC Norris Comprehensive Cancer Center scientists demonstrates that measuring circulating tumor cells (CTCs) - the cells that spread cancer through the body - may be a better predictor of patient survival than the prostate specific antigen (PSA).

24 Mar 2014

Clinical trials of new drugs to treat most aggressive form of prostate cancer

Clinical trials of new drugs to treat the most aggressive form of prostate cancer are expected to be underway in Brisbane within three years, thanks to Movember Revolutionary Team Award grant that is fast-tracking global research into the disease.

21 Mar 2014

Datamonitor Healthcare: Over half a million prostate cancer incident cases to be diagnosed this year

Over half a million cases of prostate cancer will be diagnosed worldwide in 2014, according to new research from global independent analyst firm Datamonitor Healthcare.

19 Mar 2014

Primary ADT proves ineffective in early stage prostate cancer patients

A study of more than 15,000 men with early stage prostate cancer finds that those who received androgen deprivation as their primary treatment instead of surgery or radiation did not live any longer than those who received no treatment.

19 Mar 2014

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

Porvair Sciences reports on positive commentary by researchers in published papers citing how using the fast, sensitive ChromaTrap™ Chromatin Immunoprecipitation (ChIP) technology has benefited their research.

From Chromatrap® - Porvair Sciences Ltd 18 Mar 2014

Bisphenol A may promote prostate tumourigenesis

Bisphenol A, an organic compound that is ubiquitous in plastic products, may have a direct tumourigenic effect in the prostate, US researchers have shown.

17 Mar 2014

Top medical organizations urge CMS to provide full Medicare coverage for LDCT screening

In a joint response to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group, the Lung Cancer Alliance, The Society of Thoracic Surgeons, American College of Radiology (ACR) and 38 other medical organizations called on CMS to quickly provide national Medicare coverage of low-dose computed tomography (LDCT) screening for patients at high risk for lung cancer.

17 Mar 2014

Findings reveal that miR-34 genes are bona fide tumor suppressors

Cornell University researchers report they have discovered direct genetic evidence that a family of genes, called MicroRNA-34 (miR-34), are bona fide tumor suppressors.

17 Mar 2014

Longer looks: The 'making of Obamacare;' unlocking an autistic son's secrets; antibiotics and the obesity epidemic

If you walk into a farm-supply store today, you're likely to find a bag of antibiotic powder that claims to boost the growth of poultry and livestock. That's because decades of agricultural research has shown that antibiotics seem to flip a switch in young animals' bodies, helping them pack on pounds. Manufacturers brag about the miraculous effects of feeding antibiotics to chicks and nursing calves. Dusty agricultural journals attest to the ways in which the drugs can act like a kind of superfood to produce cheap meat. But what if that meat is us? (Pagan Kennedy, 3/8).

14 Mar 2014

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

14 Mar 2014

CNIO scientist wins 2014 Stewart Rahr-PCF Young Investigator Award from Prostate Cancer Foundation

David Olmos, the Spanish National Cancer Research Centre's Head of the Prostate Cancer and Genitourinary Tumours Clinical Research Unit, has won the 2014 Stewart Rahr-PCF Young Investigator Award, endowed by the Prostate Cancer Foundation - the leading philanthropic organisation for cutting-edge research into prostate cancer.

14 Mar 2014

Study finds that older patients are undertreated

Older people globally are being denied proper access to cancer care, according to an editorial by Queen's University Belfast academic, Professor Mark Lawler of the Centre for Cancer Research and Cell Biology.

10 Mar 2014

Risk-based approach for screening men at increased risk of prostate cancer

The UK needs to invest in testing for those men most at risk of prostate cancer rather than follow a cast-the-net-wide approach targeting the whole population, a leading scientist from The University of Manchester - part of Manchester Cancer Research Centre - has argued at an international conference this week.

From The University of Manchester 10 Mar 2014

Mortality in prostate cancer lower in areas with frequent use of PSA testing

Mortality in prostate cancer is lower in areas with frequent use of PSA testing compared with areas with little testing shows a study published online today in Journal of the National Cancer Institute by researchers from Umeå University, Sweden and Memorial Sloan Kettering Cancer Center, New York, NY, USA.

10 Mar 2014

Biomarkers for bone resorption predict outcomes for men with prostate cancer

Biomarkers for bone formation and resorption predict outcomes for men with castration-resistant prostate cancer, a team of researchers from UC Davis and their collaborators have found.

10 Mar 2014

UTMB receives $3.2M grant to continue research on cancer treatments and outcomes in Texas

The Cancer Prevention and Research Institute of Texas has awarded the University of Texas Medical Branch at Galveston more than $3.2 million to continue a program aimed at creating a new state resource - a trove of population research on cancer treatments and outcomes in Texas.

10 Mar 2014

Aptel Research releases newest report Patient Voices Series Rheumatoid Arthritis

Aptel Research, a specialty marketing research and consulting company that provides actionable strategic insights to the pharmaceutical and biotech industries, released its newest report Patient Voices Series Rheumatoid Arthritis (US).

8 Mar 2014

Scientists identify important step toward shutting down growth of prostate cancer cells

Scientists at UT Southwestern Medical Center have identified an important step toward potentially shutting down the growth of prostate cancer cells.

7 Mar 2014

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

6 Mar 2014

Scientists develop reliable way of detecting prostate and bladder cancers

A new licence announced today between the University of Surrey and Randox, will bring to market a new test that will help with the early detection of prostate and bladder cancers.

From Randox Laboratories Ltd. 6 Mar 2014

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Measuring circulating tumor cells may help better predict prostate cancer survival

Clinical trials of new drugs to treat most aggressive form of prostate cancer

Datamonitor Healthcare: Over half a million prostate cancer incident cases to be diagnosed this year

Primary ADT proves ineffective in early stage prostate cancer patients

ChromaTrap™ Chromatin Immunoprecipitation technology receives positive commentary in published paper

Bisphenol A may promote prostate tumourigenesis

Top medical organizations urge CMS to provide full Medicare coverage for LDCT screening

Findings reveal that miR-34 genes are bona fide tumor suppressors

Longer looks: The 'making of Obamacare;' unlocking an autistic son's secrets; antibiotics and the obesity epidemic

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

CNIO scientist wins 2014 Stewart Rahr-PCF Young Investigator Award from Prostate Cancer Foundation

Study finds that older patients are undertreated

Risk-based approach for screening men at increased risk of prostate cancer

Mortality in prostate cancer lower in areas with frequent use of PSA testing

Biomarkers for bone resorption predict outcomes for men with prostate cancer

UTMB receives $3.2M grant to continue research on cancer treatments and outcomes in Texas

Aptel Research releases newest report Patient Voices Series Rheumatoid Arthritis

Scientists identify important step toward shutting down growth of prostate cancer cells

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Scientists develop reliable way of detecting prostate and bladder cancers

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in